World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
14543
World Ranking
2771
National Ranking
1317

Xian Chang Li publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xian Chang Li sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 278 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xian Chang Li D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xian Chang Li sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xian Chang Li is affiliated with Cornell University in the United States and has contributed extensively to the fields of medicine, immunology, and microbiology. Their research primarily focuses on immune cell function, molecular biology, oncology, and transplantation sciences. Li has a strong publication record centered on the mechanisms of immune regulation, cancer immunotherapy, and organ transplantation outcomes.

Li's work spans several subfields of study, including:

  • Immunology
  • Molecular Biology
  • Oncology
  • Surgery
  • Transplantation

Main topics addressed in their research include:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Renal Transplantation Outcomes and Treatments
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Organ Transplantation Techniques and Outcomes
  • IL-33, ST2, and ILC Pathways

Frequent co-authors in Li's collaborative research efforts include:

  • Wenhao Chen
  • Laurie J. Minze
  • Xiang Xiao
  • Dawei Zou
  • Guangchuan Wang

Li has published extensively in prominent journals such as:

  • American Journal of Transplantation
  • PubMed
  • Cellular and Molecular Immunology
  • Transplantation
  • SSRN Electronic Journal

Selected recent papers authored or co-authored by Xian Chang Li include:

  • Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate, 2020, Frontiers in Cell and Developmental Biology
  • PIRs mediate innate myeloid cell memory to nonself MHC molecules, 2020, Science
  • Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells, 2021, Nature Communications
  • Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway, 2020, Aging
  • TRIM18 is a critical regulator of viral myocarditis and organ inflammation, 2022, Journal of Biomedical Science

The scope of Li's research demonstrates a focus on immune response mechanisms, regulatory pathways in cancer and viral diseases, and therapeutic strategies related to transplantation and immunotherapy.

Best Publications

  • Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

    Yongsheng Li;Xian Chang Li;Xin Xiao Zheng;Andrew D. Wells

  • Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

    Andrew D. Wells;Xian Chang Li;Yongsheng Li;Matthew C. Walsh

  • OX40 costimulation turns off Foxp3+ Tregs.

    Minh Diem Vu;Xiang Xiao;Wenda Gao;Nicolas Degauque

  • IL-15 and IL-2: a matter of life and death for T cells in vivo.

    Xian Chang Li;Gulcin Demirci;Sylvie Ferrari-Lacraz;Chris Groves

  • Natural Killer Cells Promote Immune Tolerance by Regulating Inflammatory TH17 Cells at the Human Maternal-Fetal Interface

    Binqing Fu;Xian Chang Li;Xian Chang Li;Rui Sun;Xianhong Tong

  • NK cells promote transplant tolerance by killing donor antigen-presenting cells.

    Guang Yu;Xuemin Xu;Minh Diem Vu;Elizabeth D. Kilpatrick

  • Leptin Receptor Expression and Signaling in Lymphocytes: Kinetics During Lymphocyte Activation, Role in Lymphocyte Survival, and Response to High Fat Diet in Mice

    Elizabeth Papathanassoglou;Karim El-Haschimi;Xian Chang Li;Giuseppe Matarese

  • Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate

    Preston R. Arnold;Andrew D. Wells;Xian C. Li

  • OX40 signaling favors the induction of TH9 cells and airway inflammation

    Xiang Xiao;Savithri Balasubramanian;Wentao Liu;Xiufeng Chu

  • Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.

    Keri E Lunsford;Milind Javle;Kirk Heyne;Rachna T Shroff

  • TRIM29 promotes DNA virus infections by inhibiting innate immune response.

    Junji Xing;Ao Zhang;Hua Zhang;Jin Wang

  • T cell death and transplantation tolerance.

    Xian Chang Li;Terry B. Strom;Laurence A. Turka;Andrew D. Wells

  • Costimulatory pathways in transplantation: challenges and new developments.

    Xian Chang Li;David M. Rothstein;Mohamed H. Sayegh

  • CTLA4 Signals Are Required to Optimally Induce Allograft Tolerance with Combined Donor-Specific Transfusion and Anti-CD154 Monoclonal Antibody Treatment

    Xin Xiao Zheng;Thomas G. Markees;Wayne W. Hancock;Yongsheng Li

  • Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

    Sylvie Ferrari-Lacraz;Eric Zanelli;Manfred Neuberg;Elina Donskoy

  • Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.

    Wenda Gao;Gülçin Demirci;Terry B Strom;Xian Chang Li

  • Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract

    Junji Xing;Leiyun Weng;Bin Yuan;Zhuo Wang

  • The first case of ischemia‐free organ transplantation in humans: A proof of concept

    Xiaoshun He;Zhiyong Guo;Qiang Zhao;Weiqiang Ju

  • Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.

    Yongsheng Li;Xin Xiao Zheng;Xian Chang Li;Martin S. Zand

  • Targeting the IL-15 Receptor with an Antagonist IL-15 Mutant/Fcγ2a Protein Blocks Delayed-Type Hypersensitivity

    Yon Su Kim;Wlodzimierz Maslinski;Xin Xiao Zheng;A. Christopher Stevens

  • Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection

    Minh Diem Vu;Michael R. Clarkson;Hideo Yagita;Laurence A. Turka

  • Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1.

    U Lorenz;A D Bergemann;H N Steinberg;J G Flanagan

Frequent Co-Authors

Xin Xiao Zheng
Xin Xiao Zheng University of Pittsburgh
Terry B. Strom
Terry B. Strom Beth Israel Deaconess Medical Center
Malgorzata Kloc
Malgorzata Kloc Houston Methodist
Laurence A. Turka
Laurence A. Turka Harvard University
Mohamed H. Sayegh
Mohamed H. Sayegh American University of Beirut
Andrew D. Wells
Andrew D. Wells Children's Hospital of Philadelphia
Robert Zhong
Robert Zhong University of Western Ontario
Wenda Gao
Wenda Gao Beth Israel Deaconess Medical Center
Wayne W. Hancock
Wayne W. Hancock University of Pennsylvania
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your qualifications through online degrees can open diverse career opportunities. Nursing professionals, for instance, often explore specialized roles by pursuing certifications such as fnp to acute care certification. This allows Family Nurse Practitioners (FNPs) to transition into critical care settings, enhancing their expertise in immunological patient care.

Accelerated programs are another popular route, especially for busy professionals. Many seek out an accelerated fnp program that balances rigorous training with flexible schedules, quickly preparing students for advanced nursing roles.

Individuals starting fresh in nursing can benefit from top-tier foundational programs. The best online bsn programs for non nurses offer comprehensive, accessible pathways into the nursing field, which can later be specialized into immunology-related care.

Understanding financial prospects is equally important. Reviewing dnp salary transparency data helps prospective students and professionals gauge earning potential across different states, guiding career decisions in the immunology and broader healthcare sectors.

Best Scientists Citing Xian Chang Li

Trending Scientists

Recently Published Articles